On 25 February, La Jolla Pharmaceutical Co. (NASDAQ:LJPC) reported fourth quarter and full year 2015 financial results and highlighted 2015 corporate progress. As of December 31, 2015, La Jolla had $126.5 million in cash and cash equivalents, compared to $48.6 million as of December 31, 2014.
La Jolla Pharmaceutical Co. (NASDAQ:LJPC) belongs to Healthcare sector. Its weekly performance is 6.13%. On last trading day company shares ended up at $17.13. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) distance from 50-day simple moving average (SMA50) is 3.19%.
On 17 February, Abbott Laboratories (NYSE:ABT) said that, it is poised to surge ahead in the global point-of-care medical diagnostics industry by acquiring Alere Inc. (NYSE:ALR) of Waltham, MA, in a $5.8 billion deal which values Alere at $56 per share.
Abbott Laboratories (NYSE:ABT) shares increased 1.52% in last trading session and ended the day at $39.33. ABT Gross Margin is 57.20% and its return on assets is 10.40%. Abbott Laboratories (NYSE:ABT) quarterly performance is -12.86%.
On 29 February, Opko Health, Inc. (NYSE:OPK) reported Consolidated Revenue Increased to $276.2 Million From $25.5 Million for the Three Months Ended December 31, 2015, and Increased to $491.7 Million from $91.1 Million for the Year Ended December 31, 2015
On 01 March, Opko Health, Inc. (NYSE:OPK) shares increased 0.54% and was closed at $9.35. OPK EPS growth in last 5 year was -27.90%. Opko Health, Inc. (NYSE:OPK) year to date (YTD) performance is -6.97%.
On 24 February, Hilltop Holdings Inc. (NYSE:HTH) announced financial results for the fourth quarter and full year 2015. Hilltop produced income to common stockholders of $20.7 million, or $0.21 per diluted share, for the fourth quarter of 2015, compared to $31.7 million, or $0.35 per diluted share, for the fourth quarter of 2014.
Hilltop Holdings Inc. (NYSE:HTH) ended the last trading day at $18.13. Company weekly volatility is calculated as 6.08% and price to cash ratio as 1.80. Hilltop Holdings Inc. (NYSE:HTH) showed a weekly performance of 13.81%.
Equities research analysts at Credit Suisse assumed coverage on shares of Houghton Mifflin Harcourt Co (NASDAQ:HMHC) in a research report issued to clients and investors on Tuesday, The Fly reports. The firm set an “outperform” rating on the stock.
Houghton Mifflin Harcourt Company (NASDAQ:HMHC) shares increased 4.04% in last trading session and ended the day at $19.57. HMHC Gross Margin is 40.90% and its return on assets is -3.80%. Houghton Mifflin Harcourt Company (NASDAQ:HMHC) quarterly performance is -3.88%.